Showing results (451-460 of 1,087) with videos related to
Sort By:
Pageof 109
Thrombosis and Haemostasis|May 27, 2011
Impact of adjunctive cilostazol therapy on platelet function profiles in patients with and without diabetes mellitus on aspirin and clopidogrel therapyDominick J Angiolillo, Piera Capranzano, Jose Luis Ferreiro, et al.Circulation|September 2, 2008
Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-Thrombolysis in Myocardial Infarction 38Stephen D Wiviott, Eugene Braunwald, Dominick J Angiolillo, et al.Journal of Thrombosis and Thrombolysis|May 31, 2015
Impact of cangrelor overdosing on bleeding complications in patients undergoing percutaneous coronary intervention: insights from the CHAMPION trialsDominick J Angiolillo, Deepak L Bhatt, Ph Gabriel Steg, et al.Vascular Pharmacology|January 31, 2023
Influence of body weight and body mass index on the chronic pharmacokinetic and pharmacodynamic responses to clinically available doses of ticagrelor in patients with chronic coronary syndromesWilliam A E Parker, Dominick J Angiolillo, Fabiana Rollini, et al.Circulation. Cardiovascular Interventions|May 31, 2015
Cluster-randomized clinical trial examining the impact of platelet function testing on practice: the treatment with adenosine diphosphate receptor inhibitors: longitudinal assessment of treatment patterns and events after acute coronary syndrome prospective open label antiplatelet therapy studyTracy Y Wang, Timothy D Henry, Mark B Effron, et al.JACC. Cardiovascular Interventions|October 30, 2024
Antithrombotic Therapy in High Bleeding Risk, Part II: Noncardiac Percutaneous InterventionsMattia Galli, Felice Gragnano, Martina Berteotti, et al.JACC. Cardiovascular Interventions|October 17, 2024
Antithrombotic Therapy in High Bleeding Risk, Part I: Percutaneous Cardiac InterventionsMattia Galli, Felice Gragnano, Martina Berteotti, et al.Circulation. Cardiovascular Quality and Outcomes|December 12, 2019
Systematic Evaluation of the Robustness of the Evidence Supporting Current Guidelines on Myocardial Revascularization Using the Fragility IndexMario Gaudino, Irbaz Hameed, Giuseppe Biondi-Zoccai, et al.Journal of the American College of Cardiology|March 26, 2016
Crushed Prasugrel Tablets in Patients With STEMI Undergoing Primary Percutaneous Coronary Intervention: The CRUSH StudyFabiana Rollini, Francesco Franchi, Jenny Hu, et al.Journal of the American College of Cardiology|May 5, 2012
Pharmacodynamic effects of prasugrel dosing regimens in patients on maintenance prasugrel therapy: results of a prospective randomized studyAntonio Tello-Montoliu, Salvatore D Tomasello, José Luis Ferreiro, et al.Pageof 109